MARKET

BFRIW

BFRIW

Biofrontera
NASDAQ
0.0293
+0.0044
+17.67%
Closed 15:51 08/18 EDT
OPEN
0.0297
PREV CLOSE
0.0249
HIGH
0.0297
LOW
0.0232
VOLUME
11.45K
TURNOVER
0
52 WEEK HIGH
0.1500
52 WEEK LOW
0.0201
MARKET CAP
--
P/E (TTM)
-0.0264
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BFRI last week (0810-0814)?
Weekly Report · 2d ago
Biofrontera GAAP EPS of -$0.05, revenue of $12M
Seeking Alpha · 6d ago
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
NASDAQ · 6d ago
*Biofrontera 2Q Loss/Shr 5c >BFRI
Dow Jones · 6d ago
*Biofrontera 2Q Net Product Rev $12.0M >BFRI
Dow Jones · 6d ago
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
Barchart · 6d ago
Weekly Report: what happened at BFRI last week (0803-0807)?
Weekly Report · 08/10 10:28
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
NASDAQ · 08/07 12:20
More
About BFRIW
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. Its second prescription drug licensed product in its portfolio is Xepi, which is a topical non-fluorinated quinolone that inhibits bacterial growth and used for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.

Webull offers Biofrontera Inc stock information, including NASDAQ: BFRIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRIW stock methods without spending real money on the virtual paper trading platform.